KINIKSA PHARMACEUTICALS LTD shareholders Q3 2023

KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 139 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.

KINIKSA PHARMACEUTICALS LTD shareholders Q3 2023
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 2,474,561$42,983,1255.17%
Rubric Capital Management LP 3,077,449$53,455,2892.00%
Parkman Healthcare Partners LLC 509,810$8,855,4001.62%
TANG CAPITAL MANAGEMENT LLC 600,000$10,422,0001.47%
AlphaCentric Advisors LLC 110,000$1,910,7001.08%
Lion Point Capital, LP 130,691$2,270,1031.01%
RICE HALL JAMES & ASSOCIATES, LLC 650,366$11,296,8570.72%
ESSEX INVESTMENT MANAGEMENT CO LLC 185,853$3,228,2670.53%
ADVISORY RESEARCH INC 204,098$3,545,1820.49%
Jackson Creek Investment Advisors LLC 65,607$1,1400.48%
Linden Thomas Advisory Services, LLC 115,891$2,013,0270.45%
Birchview Capital, LP 30,000$521,1000.44%
EAM Investors, LLC 124,438$2,161,4880.42%
Tejara Capital Ltd 35,000$607,9500.34%
Granahan Investment Management 534,214$9,279,2970.33%
GMT CAPITAL CORP 477,853$8,300,3070.31%
Baker Brothers Advisors 2,809,577$48,802,3520.28%
HHLR ADVISORS, LTD. 698,741$12,137,1310.27%
Soleus Capital Management, L.P. 157,349$2,733,1520.25%
Virtus ETF Advisers LLC 18,461$320,6680.20%
External links

This page lists KINIKSA PHARMACEUTICALS LTD's shareholders in Q3 2023. To view KINIKSA PHARMACEUTICALS LTD's shareholder history, click here.